Jondetech

JONDETECH AS AN INVESTMENT

JonDeTech is developing the sensor technology behind the next generation of digital health. With a patented digital sensor platform, growing customer validation and a scalable business model, the Company is positioning itself for long-term growth in fast-growing global markets.

Here you will find financial reports, share information and the latest updates on JonDeTech’s commercial and strategic progress.

The next generation of digital health starts with better physiological data

Healthcare is moving from reactive treatment to continuous, personalized monitoring. The next generation of wearables will not be defined by more features, but by better physiological data.

JonDeTech has developed a patented digital sensor technology designed to enable continuous Core Body Temperature (CBT) monitoring in next-generation consumer products. By combining ultra-thin design, ultra-low power consumption and cost-efficient manufacturing, our technology enables applications where traditional solutions have been too large, too power-hungry or too expensive.

Today, customer projects, design wins and commercial orders are validating both our technology and our commercial strategy. As demand for digital health accelerates, JonDeTech is preparing for scalable production and future high-volume deliveries.

Next Generation Health
CBT City

Strategy & Business Model

JonDeTech focuses on high-volume applications where compact, low-power temperature sensing creates significant customer value.

Our commercial strategy is based on converting customer projects into design wins, design wins into commercial products, and commercial products into long-term sensor deliveries. Through distributors, strategic partners and direct customer relationships, we target global markets within digital health, wearables and industrial applications.

Positioned at the Intersection of Fast-Growing Markets

JonDeTech’s technology is positioned where several long-term growth trends converge. The rapid expansion of digital health, medical wearables and next-generation consumer devices is creating increasing demand for continuous physiological monitoring. By enabling continuous Core Body Temperature measurement in mass-produced products, JonDeTech addresses opportunities across multiple fast-growing markets rather than a single application.

Go to market strategy

Commercialization begins with customer evaluation projects, where JonDeTech works closely with customers to understand product requirements while demonstrating how our technology can create value.

Successful evaluations lead to design wins, followed by industrialization, production planning and ultimately high-volume sensor deliveries. This structured commercial process enables long-term customer relationships and recurring revenue opportunities.

Scalable business model

JonDeTech operates a scalable fabless business model designed for high-volume markets.

Manufacturing is performed by carefully selected production partners, enabling efficient scaling without major manufacturing investments. As customer demand grows, production capacity can increase while maintaining an asset-light business model.

Supplier model & customer segment

JonDeTech is part of a global electronics ecosystem where sensor manufacturers, module suppliers, ODMs and OEMs work together to bring new products to market.

Our sensors are designed to integrate seamlessly into products such as smartwatches, smart rings, medical wearables, industrial safety solutions and other connected devices, creating opportunities across multiple fast-growing industries.

Customer Validation

Customer validation is a key milestone in JonDeTech’s commercial journey.

Our growing number of customer projects, multiple design wins and first commercial order demonstrate increasing market acceptance of our technology. Every successful customer project strengthens both our commercial pipeline and our position as a technology partner for next-generation digital health products.

Attached you will find the latest version of the company's IR presentation.